Clinical implications of N-cadherin expression in gastric cancer

Pathology International

Volumn 62, Issue 3, 2012, Pages 161-166

  Kamikihara, Takahito ^a   Ishigami, Sumiya ^a   Arigami, Takaaki ^a   Matsumoto, Masataka ^a   Okumura, Hiroshi ^a   Uchikado, Yasuto ^a   Kita, Yoshiaki ^a   Kurahara, Hiroshi ^a   Kijima, Yuko ^a   Ueno, Shinichi ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

E cadherin; Gastric cancer prognosis; N cadherin

Indexed keywords

AVIDIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; FEMALE; GASTRECTOMY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84857483545     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02774.x     Document Type: Article

References (24)

1. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: The Japanese approach. Semin Oncol 1996; 23: 360-68.
2. Chen HC, Chu RY, Hsu PN etal. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 2003; 201: 97-106.
3. Zhou YN, Xu CP, Han B etal. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8: 987-93.
4. Utsunomiya T, Doki Y, Takemoto H etal. Clinical significance of disordered beta-catenin expression pattern in human gastric cancers. Gastric Cancer 2000; 3: 193-201.
5. Yasui W, Kuniyasu H, Akama Y etal. Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas-correlation with histology and tumor progression. Oncol Rep 1995; 2: 111-17.
6. Pötter E, Bergwitz C, Brabant G. The cadherin-catenin system: Implications for growth and differentiation of endocrine tissues. Endocr Rev 1999; 20: 207-39.
7. Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003; 120: 1351-83.
8. Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 2005; 27: 1677-83.
9. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
10. Natalwala A, Spychal R, Tselepis C. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 2008; 14: 3792-7.
11. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M. Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs 2007; 185: 191-203.
12. Han AC, Soler AP, Knudsen KA, Salazar H. Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol 1999; 30: 1035-9.
13. Tomita K, van Bokhoven A, van Leenders GJ etal. Cadherin switching in human prostate cancer progression. Cancer Res 2000; 60: 3650-54.
14. Giroldi LA, Bringuier PP, Shimazui T, Jansen K, Schalken JA. Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int J Cancer 1999; 82: 70-76.
15. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996; 135: 1643-54.
16. Rosivatz E, Becker I, Bamba M etal. Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int J Cancer 2004; 111: 711-19.
17. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
18. Xiangming C, Hokita S, Natsugoe S etal. Co-occurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology 1999; 57: 131-7.
19. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147: 631-44.
20. Yi Kim D, Kyoon Joo J, Kyu Park Y etal. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol 2007; 96: 429-35.
21. Tran NL, Nagle RB, Cress AE, Heimark RL. N-Cadherin expression in human prostate carcinoma cell lines: An epithelial-mesenchymal transformation mediating adhesion with Stromal cells. Am J Pathol 1999; 155: 787-98.
22. Koshikawa N, Minegishi T, Nabeshima K, Seiki M. Development of a new tracking tool for the human monomeric laminin-gamma 2 chain in vitro and in vivo. Cancer Res 2008; 68: 530-36.
23. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007; 13: 7003-11.
24. Nakajima S, Doi R, Toyoda E etal. N-cadherin expression and epithelial -mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 2004; 10: 4125-33.